Shareholders Equity: The sum of preferred and common equity items.
Ono Pharmaceutical Co. (OPHLF) had Shareholders Equity of $5.42B for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.85B |
|
$704.44M |
|
$4.29B |
|
$7.14B |
|
$804.13M |
|
$742.50M |
|
$917.20M |
|
$1.72B |
|
$5.42B |
|
$2.93B |
|
|
Shareholders Equity |
$5.42B |
1.41B |
|
| Cash Flow Statement Financials | |
$286.86M |
|
$-1.00B |
|
$683.74M |
|
$1.10B |
|
$1.06B |
|
$-34.05M |
|
-- |
|
$-241.13M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|